Absci Corporation ABSI

Updated: 9 Aug 2026

NASDAQ | Biotech | Generative AI drug creation

No signal published yet

We already track Absci and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Absci free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Generative AI drug creation
We're already tracking Absci Corporation — here are the latest events we've registered

Recent News

  • In June 2026, Absci announced positive interim Phase 1 data from its HEADLINE trial of ABS-201, demonstrating favorable safety and tolerability. Concurrently, the company priced a $100 million underwritten public offering to fund the continued advancement of its pipeline. In July 2026, Absci announced that it will report its second-quarter 2026 financial results on August 11, 2026.

What Firelda Watch includes for Absci Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Absci Corporation will be delivered in the same format.

Want to follow Absci Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Absci free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Absci Corporation ABSI
Absci — follow and we'll monitor it
Follow Absci free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.